TigerTox: @pmrgroup Thanks for RT!
TigerTox: @cristianespinel Thanks for RT!
TigerTox: #FDA Changes Expected with #PDUFA V | TigerTox http://t. nhs ivermectin co/hTn6nTtH #in #nonclinical #preclinical #drug safety
The average cost of developing a drug was $1.3 billion as of January 2011. The average first-cycle approval rate for standard new molecular entities (NME) has increased from an average of 30% in 1992 to 38% this year. Priority NMEs have fared better with the FDA,...
TigerTox: #FDA Flexible on #Rare Disease Treatments http://t.co/XSqeStu3 #in #pharma #orphan drugs. More details.
